Jasper Therapeutics Inc
NASDAQ:JSPR
Jasper Therapeutics Inc
NASDAQ:JSPR
Price:
0.9659
USD
-8.01%
Market Closed
Market Cap:
$27m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Jasper Therapeutics Inc
NASDAQ:JSPR
|
US |
|
Skipper Ltd
NSE:SKIPPER
|
IN |
|
C
|
China Spacesat Co Ltd
SSE:600118
|
CN |
|
G
|
Greentech Technology International Ltd
HKEX:195
|
HK |
|
Toyou Feiji Electronics Co Ltd
SZSE:300302
|
CN |
|
Prevas AB
LSE:0H2J
|
SE |
|
B
|
Brembo SpA
MIL:BRE
|
IT |
|
Swiftmerge Acquisition Corp
NASDAQ:ANNA
|
CA |
|
S
|
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
|
CN |
Balance Sheet
Balance Sheet Decomposition
Jasper Therapeutics Inc
Jasper Therapeutics Inc
Balance Sheet Decomposition is not available for
Jasper Therapeutics Inc
Jasper Therapeutics Inc
Balance Sheet
Jasper Therapeutics Inc
Jasper Therapeutics Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
27
|
20
|
85
|
38
|
87
|
72
|
29
|
|
| Cash Equivalents |
27
|
20
|
85
|
38
|
87
|
72
|
29
|
|
| Total Receivables |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
3
|
2
|
4
|
6
|
|
| Total Current Assets |
27
|
21
|
88
|
42
|
89
|
76
|
35
|
|
| PP&E Net |
0
|
2
|
5
|
5
|
4
|
3
|
1
|
|
| PP&E Gross |
0
|
2
|
5
|
5
|
4
|
3
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
4
|
5
|
|
| Other Long-Term Assets |
0
|
1
|
1
|
1
|
2
|
1
|
1
|
|
| Total Assets |
27
N/A
|
23
-14%
|
94
+301%
|
48
-48%
|
95
+96%
|
80
-16%
|
36
-55%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
1
|
4
|
2
|
4
|
4
|
6
|
|
| Accrued Liabilities |
1
|
3
|
4
|
5
|
8
|
11
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
0
|
0
|
1
|
0
|
|
| Total Current Liabilities |
2
|
4
|
8
|
7
|
12
|
15
|
13
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
4
|
11
|
16
|
5
|
4
|
3
|
18
|
|
| Total Liabilities |
6
N/A
|
15
+140%
|
24
+65%
|
12
-49%
|
16
+33%
|
18
+11%
|
32
+74%
|
|
| Equity | ||||||||
| Common Stock |
26
|
44
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
5
|
37
|
67
|
105
|
170
|
241
|
317
|
|
| Additional Paid In Capital |
0
|
2
|
137
|
141
|
248
|
303
|
321
|
|
| Total Equity |
21
N/A
|
9
-59%
|
70
+698%
|
36
-48%
|
78
+118%
|
62
-21%
|
4
-93%
|
|
| Total Liabilities & Equity |
27
N/A
|
23
-14%
|
94
+301%
|
48
-48%
|
95
+96%
|
80
-16%
|
36
-55%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
5
|
5
|
4
|
5
|
11
|
15
|
28
|
|
Switch to:
Switch to:
See Also
Discover More
